KNSA - Kiniksa Pharmaceuticals International, plc


46.02
-1.250   -2.716%

Share volume: 729,576
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%

$47.27
-1.25
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 04-25-2024 07-25-2024 10-29-2024 02-25-2025 04-29-2025 07-29-2025 10-28-2025 02-24-2026
Total revenue 79.858 M 108.631 M 112.214 M 122.536 M 137.785 M 156.797 M 180.855 M 202.127 M
Cost of revenue 31.384 M 42.336 M 49.416 M 66.085 M 61.658 M 71.021 M 83.564 M 90.975 M
Gross profit 48.474 M 66.295 M 62.798 M 56.451 M 76.127 M 85.776 M 97.291 M 111.152 M
    36.76% -5.27% -10.11% 34.86% 12.67% 13.42% 14.25%  
Operating expenses 65.016 M 66.412 M 72.456 M 75.750 M 62.855 M 65.616 M 73.270 M 91.384 M
Selling general and admin 38.682 M 42.395 M 46.399 M 40.535 M 43.530 M 46.863 M 49.104 M 56.775 M
Research and development 26.334 M 24.017 M 26.057 M 35.215 M 19.325 M 18.753 M 24.166 M 34.609 M
Total expenses 65.016 M 66.412 M 72.456 M 75.750 M 62.855 M 65.616 M 73.270 M 91.384 M
    2.15% 9.10% 4.55% -17.02% 4.39% 11.66% 24.72%  
Operating income -16.542 M -117.000 K -9.658 M -19.299 M 13.272 M 20.160 M 24.021 M 19.768 M
Ebit -14.276 M 2.304 M -7.201 M -16.979 M 15.565 M 22.877 M 27.157 M 23.269 M
Pretax income -14.276 M 2.304 M -7.201 M -16.979 M 15.565 M 22.877 M 27.157 M 23.269 M
    -116.14% -412.54% 135.79% -191.67% 46.98% 18.71% -14.32%  
Income tax 3.428 M 6.212 M 5.492 M -8.091 M 7.026 M 5.045 M 8.722 M 9.070 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -17.704 M -3.908 M -12.693 M -8.888 M 8.539 M 17.832 M 18.435 M 14.199 M
    77.93% -224.80% 29.98% 196.07% 108.83% 3.38% -22.98%